Guardion Health Sciences to Present at Benzinga Global Small Cap Conference | Nation / World

HOUSTON, December 03, 2021 (GLOBE NEWSWIRE) – Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition and diagnostic company that develops clinically supported nutrition, foods devices, supplements and medical devices, today announces that Chief Executive Officer Bret Scholtes will present an overview of the company at the Benzinga Global Small Cap conference, to be held virtually from December 8 to 9, 2021.

Mr. Scholtes will make his corporate presentation on Thursday, December 9 at 3 p.m. ET.

Mr. Scholtes will be available for one-on-one meetings throughout the conference.

Register for the conference:

Global: December 8-9

About Guardion Health Sciences, Inc.

Guardion Health Sciences, Inc. (Nasdaq: GHSI) is a clinical nutrition and diagnostic company. Guardion’s portfolio of scientifically supported and clinically supported nutrition, medical foods and diagnostics products help healthcare professionals, their patients and consumers achieve their health goals. Guardion’s business and development initiatives are supported by equally impressive scientific and medical advisory boards, led by senior business executives and physicians with many years of experience. This combination of expertise and scientific knowledge forms the basis of Guardion’s growing position in the clinical nutrition market. Information and risk factors regarding Guardion and its business, including its ability to successfully develop and market its proprietary products and technologies, may be obtained from the documents filed by the Company with the United States Securities and Exchange Commission. (the “SEC”) at www.sec .gov.

Disclaimer Regarding Forward-Looking Statements

Except for historical information contained in this press release, the matters described in this document may contain forward-looking statements within the meaning of section 27A of the Securities Act of 1933, as amended, and section 21E of the Securities Exchange Act of 1934, as amended. Statements preceded, followed or which otherwise include the words “believes”, “expects”, “anticipates”, “intends”, “projects”, “estimates”, “plans” and similar expressions or Future or conditional verbs such as “” will “,” should “,” would “,” could “and” could “are generally forward-looking in nature and not historical facts, although all forward-looking statements do not include the foregoing . These statements involve unknown risks and uncertainties which may have an individual or material impact on the matters discussed in this document for various reasons beyond the control of the Company, including, but not limited to, the ability of the Company. Company to raise sufficient funding to implement its activities. plan, the integration of a new management team, the integration of one or more acquisitions and targets, the impact of the COVID-19 pandemic on the business, operations and economy in general of the Company , the Company’s ability to successfully develop and commercialize its products and technologies, and the Company’s ability to maintain compliance with Nasdaq listing requirements. Readers are cautioned not to place undue reliance on these forward-looking statements, as actual results could differ materially from those described in the forward-looking statements contained herein. Readers are urged to read the risk factors set out in the Company’s filings with the SEC, which are available on the SEC’s website ( The Company disclaims any intention or obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

Investor Relations Contact:


Scott arnold


[email protected]

Contact person for media relations:

Jules Abraham

Director of Public Relations



[email protected]

Copyright 2021 GlobeNewswire, Inc.

Previous Cyber ​​security conference a big hit with young Saudi programmers
Next Nightclubs in Ireland to close next week, concert hall capacity reduced to 50%